Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered CRISPR-Cas9 nucleases with altered PAM specificity

Engineered CRISPR-Cas9 nucleases with altered PAM specificity

US Patent 11859220 · Granted Jan 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered human-endogenous virus-like particles and methods of use thereof for 2025
Engineered human-endogenous virus-like particles and methods of use thereof for 2025
Engineered human-endogenous virus-like particles and methods of use thereof for 2025
Enhanced virus-like particles and methods of use thereof for delivery to cells2025
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants2025
Methods for increasing efficiency of nuclease-induced homology-directed repair2025
Methods for increasing efficiency of nuclease-induced homology-directed repair2025
CRISPR-Cas enzymes with enhanced on-target activity2025
Engineered CRISPR-Cas9 nucleases with altered PAM specificity2025
Engineered CRISPR-Cas9 nucleases with altered PAM specificity2025
Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf12025
Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf12025